Suppr超能文献

强心剂Org10325在离体心脏和血管组织制剂中的药理和生化作用。

Pharmacological and biochemical effects of the cardiotonic agent Org10325 in isolated cardiac and vascular tissue preparations.

作者信息

Shahid M, Martorana M G, Cottney J E, Marshall R J

机构信息

Department of Pharmacology, Organon Laboratories Limited, Newhouse, Lanarkshire.

出版信息

Br J Pharmacol. 1990 Aug;100(4):735-42. doi: 10.1111/j.1476-5381.1990.tb14084.x.

Abstract
  1. The pharmacological and biochemical effects of a novel cardiotonic agent, Org10325 have been studied in isolated cardiac and vascular tissue preparations. 2. Org10325 produced concentration-dependent (0.15-4.8 mM) positive inotropic, positive chronotropic and vascular relaxant responses in rabbit isolated papillary, atrial and aortic preparations, respectively. The maximal chronotropic effect (45%) was significantly less than the isoprenaline maximum. The inotropic effects of Org10325 were not modified by alpha- or beta-adrenoceptor blockade or by pretreatment with reserpine. Org10325 was at least 23 times more potent at relaxing aortic strips pre-contracted with phenylephrine than with KCl. 3. Org10325 (74 microM) potentiated (10-14 fold) the positive inotropic effects of isoprenaline in rabbit isolated papillary muscles. Carbachol inhibited the positive inotropic effect of Org10325. Both the positive inotropic and vasorelaxant effects of Org10325 were accompanied by increases in cyclic AMP but not cyclic GMP. 4. In rat perfused heart preparation Org10325 increased phosphorylase a, cyclic AMP-dependent protein kinase activities and stimulated phosphorylation of contractile proteins (troponin-I and C-protein). 5. Org10325 selectively inhibited the cyclic AMP hydrolytic activity of cyclic AMP high affinity cyclic nucleotide phosphodiesterase (PDE) isoenzymes, PDE III (IC50 65 microM) and PDE IV (IC50 71 microM), from rabbit cardiac ventricle. Weak inhibition (IC50 greater than 250 microM) of PDE I and PDE II was observed. 6. The results show that the cardiac and vascular effects of Org10325 are mediated by an increase in cellular cyclic AMP due to inhibition of PDE III and PDE IV activities. However, in contrast to other PDE-inhibitors OrglO325 produced a marked increase in relaxation time of isolated papillary muscle suggesting the involvement of additional cyclic AMP-independent mechanisms of action.
摘要
  1. 一种新型强心剂Org10325的药理和生化作用已在离体心脏和血管组织制备物中进行了研究。2. Org10325在兔离体乳头肌、心房和主动脉制备物中分别产生浓度依赖性(0.15 - 4.8 mM)的正性肌力、正性变时和血管舒张反应。最大变时效应(45%)明显小于异丙肾上腺素的最大值。Org10325的正性肌力作用不受α或β肾上腺素能受体阻断或利血平预处理的影响。Org10325在舒张用去氧肾上腺素预收缩的主动脉条方面比舒张用氯化钾预收缩的主动脉条至少强23倍。3. Org10325(74 microM)增强(10 - 14倍)了异丙肾上腺素在兔离体乳头肌中的正性肌力作用。卡巴胆碱抑制Org10325的正性肌力作用。Org10325的正性肌力和血管舒张作用均伴随着环磷酸腺苷(cAMP)而非环磷酸鸟苷(cGMP)的增加。4. 在大鼠离体心脏制备物中,Org10325增加了磷酸化酶a、环磷酸腺苷依赖性蛋白激酶活性,并刺激了收缩蛋白(肌钙蛋白I和C蛋白)的磷酸化。5. Org10325选择性抑制来自兔心室的环磷酸腺苷高亲和力环核苷酸磷酸二酯酶(PDE)同工酶PDE III(IC50 65 microM)和PDE IV(IC50 71 microM)的环磷酸腺苷水解活性。观察到对PDE I和PDE II的弱抑制(IC50大于250 microM)。6. 结果表明,Org10325的心脏和血管作用是由于抑制PDE III和PDE IV活性导致细胞内环磷酸腺苷增加所介导的。然而,与其他PDE抑制剂不同的是,Org10325使离体乳头肌的舒张时间显著增加,提示存在其他不依赖环磷酸腺苷的作用机制。

相似文献

本文引用的文献

3
Role of cyclic nucleotides in heart metabolism.环核苷酸在心脏代谢中的作用。
Cardiovasc Res. 1982 Sep;16(9):483-507. doi: 10.1093/cvr/16.9.483.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验